Taking CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A) for example, it ranked high in the list of homozygous deletion and methylation difference and was a significant prognostic risk factor for PCa. Here, CDKN2A is linked to posterior cortical atrophy.